Speakers
Prof. Dr. Juan Antonio Mico – Universidad de Cadiz, Espanha
Juan Antonio Micó, is graduated in Medicine from the University of Cádiz (Spain). Professor Micó obtained a doctorate PhD in Medical Sciences (Cádiz, Spain) and another doctorate PhD in Biology Humaine Mention: Neuropsychopharmacology. (University Pierre et Marie Curie, Paris, France). He is Professor of Neuropsychopharmacology at the University of Cádiz (Spain) and Director of the Department of Neuroscience, Pharmacology and Psychiatry also Director of Spanish Mental Health Network (University of Cadiz Unit/Node G18), CIBER of Mental Health, CIBERSAM. He has published 116 articles in JCR, reviews and book chapters related with the pharmacological mechanisms of action of psychopharmacological drugs.
Prof. Dr. Elisaldo Luiz de Araújo Carlini – Diretor do CEBRID, UNIFESP, Brazil
Elisaldo Luiz de Araújo Carlini, is graduated in medicine from the Federal University of São Paulo and a master in Psychopharmacology – Yale University. Currently, he is professor at the Federal University of São Paulo, member of the Expert Advisory Panel on Drug Dependence and Alcohol Problems (7th Term) – World Health Organization (WHO), former member of the International Narcotic Control Board (INCB), elected by the Phytotherapy Research and Journal of Ethnopharmacology, coordinator of the Scientific Technical Advisory Board of the National Anti-Drug Secretariat (SENAD). Has experience in the area of Pharmacology acting mainly in the following subjects: drugs, epidemiological surveys, medicinal plants. Adviser of Master’s and Doctorate of the Department of Preventive Medicine of UNIFESP.
Dr. David Roberson – Boston Children’s Hospital, Blue Therapeutics – Boston, USA
David Roberson provides operational and project management expertise at Blue Therapeutics. He spent nearly a decade developing novel analgesics, anti-pruritics and antitussives under the direction of the Harvard Medical School pain neurobiologist, Clifford Woolf, MD, PhD. He is an inventor on numerous drug- and drug development-related patents, and has >10 peer-reviewed research publications focused on preclinical drug development. David received his M.B.A. from Harding University and his Ph.D. in Neuroscience from Harvard University.
Prof. Dr. Sebastien Talbot – Department of Pharmacology and Physiology
University of Montreal, Montreal, Canada
Sebastien Talbot, is graduated in Pharmacology from the Université de Sherbrooke (Canada). Dr Sebastien obtained a doctorate PhD in Physiology in 2012 from the Université de Montréal, Canada . He is Assistant Professor of Faculty of Medicine. Dept of Pharmacology and Physiology and Tier-2 Canada Research Chair. He is coordinator of Talbot Lab thats aims to define a framework of the neuro-immune interplay at the system level, to decipher how and which sub-population of sensory neurons controls innate and adaptive responses, and to develop new targeted therapies for resolution of chronic inflammatory diseases.